PMC:7195088 / 12402-12571 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"180","span":{"begin":107,"end":115},"obj":"Species"},{"id":"208","span":{"begin":43,"end":61},"obj":"Chemical"},{"id":"254","span":{"begin":98,"end":106},"obj":"Disease"}],"attributes":[{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"Tax:9606"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"MESH:D006886"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"pending RCT results, in our opinion, early hydroxychloroquine administration may be considered in COVID-19 patients manifesting moderate to severe symptoms, whereas furt"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T63","span":{"begin":98,"end":106},"obj":"Disease"}],"attributes":[{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"pending RCT results, in our opinion, early hydroxychloroquine administration may be considered in COVID-19 patients manifesting moderate to severe symptoms, whereas furt"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":43,"end":61},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"pending RCT results, in our opinion, early hydroxychloroquine administration may be considered in COVID-19 patients manifesting moderate to severe symptoms, whereas furt"}